DUBLIN--(BUSINESS WIRE)--The "North America Pneumonia Testing Market Analysis (2017-2023)" report has been added to ResearchAndMarkets.com's offering.
The North America Pneumonia Testing Market is expected to witness market growth of 8.2% CAGR during the forecast period (2017-2023).
The demand for pain management drugs in the recent years is on the rise. POC testing is a revolutionary technology, which is now an ideal technique that is used in detecting pneumonia. The POC test can be carried out from the comfort of one's home to bedside diagnosis in hospitals. Growing popularity for POC tests within the healthcare sector is expected to enhance the market attractiveness during the forecast period. Research and development activities are on the rise for the development of more advanced PCR-based technologies which could be used for faster results.
Based on method, the market report segments the market into Immunodiagnostics, Molecular Diagnostics, and Point-Of-Care (POC) Testing. The end user segment covers Hospitals, Diagnostic Centers, Homecare, and Others.
Based on type, the market is segmented into Analyzers and Consumables.
The technology covered under the report includes Enzyme-Linked Immunosorbent Assay (ELISA), Immunofluorescence, Western Blot, Polymerase Chain Reaction (PCR), Immunohistochemistry (IHC), and Others.
The report also covers country wise segmentation of Pneumonia Testing market. The countries included in the report are US, Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the North America Pneumonia Testing Market.
Key Topics Covered
1. Market Scope & Methodology
2. Market Overview
3. North America Pneumonia Testing Market
4. North America Pneumonia Testing Market by End User
5. North America Pneumonia Testing Market by Method
6. North America Pneumonia Testing Market by Technology
7. North America Pneumonia Testing Market by Country
8. Company Profiles
- Abbott Laboratories
- Becton, Dickinson and Company
- Bio-Rad Laboratories, Inc.
- F. Hoffmann-La Roche AG
- Hologic, Inc.
- Meridian Bioscience Inc.
- Quest Diagnostics Incorporated
- Quidel Corporation
- Thermo Fisher Scientific
For more information about this report visit https://www.researchandmarkets.com/research/s65jtn/2018_pneumonia?w=4